Search for: "LANGE v. USA" Results 21 - 40 of 87
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2021, 8:33 am by Pamela C. Maloney
Circuit Judge Newman filed a dissention opinion to express her view that the patent described a patent-eligible mechanical and electronic device of defined structure and mechanism (Yu v. [read post]
” The Federal Circuit also held that the defendants were entitled to sanctions in the form of appellate attorney fees and double costs, against both the complaining individual and his legal counsel (Pirri v. [read post]
Another topic to evaluate is how patent protection strategies are pursued in parallel to clinical and commercial activities related to COVID-19 vaccines, diagnostics, and therapeutics (for example, the authors of a recent Lancet paper about the Sputnik V vaccine are named as inventors in a series of Russian patent documents published between May and September 2020 and in a PCT application published in January 2021). [read post]
On 4 December 2020, the English Patents Court handed down its decision in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited, the main action proceedings regarding Neurim’s patent for Circadin, EP 1 441 702 (“EP 702”). [read post]
9 Oct 2020, 4:47 am by Pamela C. Maloney
The patent owner did not establish that the Board erred in its finding that the challenged claims were obvious in light of the prior art (Siemens Mobility, Inc. v. [read post]
29 Aug 2020, 9:49 pm by Nicole D. Prysby
” These declarations alleged only “possible future injury” and failed to establish a substantial risk of harm (Association for Accessible Medicines v. [read post]
24 Aug 2020, 4:20 am by Florence Campbell Jones
In her judgment, handed down in April 2020, Mrs Justice Lang found that the NCA’s assumptions relating to the requirements which must be met in order to obtain a UWO were “unreliable”. [read post]
Nor did the Board err by considering design drawings submitted by the review petitioner as proof of design elements that were known in the art at the critical time of the challenged patents (B/E Aerospace, Inc. v. [read post]
3 Feb 2020, 5:39 am by Brian Craig
” The Federal Circuit construed the language consistently with the protocol described in the specification (SIPCO, LLC v. [read post]
28 Dec 2019, 2:15 am by Thomas Long
In addition, because the district court’s decisions on equitable matters—including a prospective royalty rate for the SEP portfolio—were based on issues common to the improperly adjudicated release payment, the district court’s decision was overturned in full and remanded for further proceedings, including a jury trial on the release payment rate (TCL Communication Technology Holdings Ltd. v. [read post]
25 Nov 2019, 2:34 am by Cheryl Beise
” Judge Dyk would hear the decisions on the merits, rather than vacate them for a new hearing before a new panel below (BedGear, LLC v. [read post]
22 Oct 2019, 9:09 am by George Basharis
The federal district court in Minnesota properly denied Bombardier’s post-trial motion for judgment as a matter of law, the Federal Circuit ruled, rejecting Bombardier’s contention that the strength of its evidence was sufficient to nullify the jury’s verdict (Bombardier Recreational Products Inc. v. [read post]